RVC Biofund

📍 Moscow, Russia🗓 Founded 2011👥 3 employees💰 Last funded Feb 2015
In June 2010 the Board of Directors of RVC has approved the Conceptual Framework of RVC Biofund. In early 2011, the fund started its operations. The Biofund was necessitated by a low share of Russian innovative drugs, amounting today to less than 1%. With virtually zero infrastructure to develop biopharma and medical start-ups, foreign services devour 50% to 80% of Russian investment resources. To remedy this, RVC BioFund will be investing capital into service companies of this cluster and biotech start-ups. Additionally, it will be launching an ecosystem to generate and incubate as many biotech projects as possible. The Fund focus covers innovative biopharma companies and service companies providing contract, laboratory, analytical and consulting services to biotechnological, pharmaceutical and medical companies.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2011
Founded
Investor geography1 country
Russia
1
Frequently asked questions
Who invested in RVC Biofund?
RVC Biofund has 1 investors on record on gritt.io, 1 mid-stage.
When did RVC Biofund last raise funding?
The most recent investment in RVC Biofund recorded on gritt.io was in February 2015.
When was RVC Biofund founded?
RVC Biofund was founded in 2011.
What industry is RVC Biofund in?
RVC Biofund operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.
Where is RVC Biofund based?
RVC Biofund is headquartered in Moscow, Russia.